- Home
- About Us
- Industry
- Services
- Reading
- Contact Us
Author: Vikas Kumar
April 11, 2023
Global Multiplex Assay market is expected to register a CAGR of approx. 7% over the period of 2022-2028. Multiplex assay is a type of biological assay that allows simultaneous measurement of multiple analytes (such as proteins, nucleic acids, or metabolites) in a single sample. This technique has gained increasing popularity in the field of biotechnology and biomedical research due to its ability to provide comprehensive information on multiple biomolecules at once. The growing demand for multiplex assay can be attributed to the expanding need for research and development in the fields of molecular diagnostics and companion diagnostics which boosts the adoption of organic growth strategies among key industry players around the globe. For instance, in response to the COVID-19 outbreak, Thermo Fisher Scientific developed a multiplex real-time PCR diagnostic kit (TaqPath COVID-19 Multiplex Diagnostic Solution) to facilitate public and clinical health laboratories to rapidly diagnose SARS-CoV-2 infection.
Request for Sample of the report browse through- https://univdatos.com/report/multiplex-assay-market/get-a-free-sample-form.php?product_id=36274
Based on the technology, the multiplex assay market is segmented into multiplex real-time PCR, flow cytometry, and others. The multiplex real-time PCR segment accounted for a significant market share, and it is estimated that it will grow rapidly during the projected timeframe. PCR technology is widely used in a variety of end-use applications. Furthermore, the widespread use of PCR technologies for COVID-19 detection has resulted in significant revenue generation by this technology.
Based on the application, the market is fragmented into clinical diagnostics and research & development. The research & development segment grabbed a considerable market share during the forecast period. Multiplex assays are becoming more and more used in the drug discovery process. These tests are employed in preclinical and clinical phases to assess drug response biomarkers, immunotherapy efficacy, and toxicity.
For a detailed analysis of the Global Multiplex Assay Market browse through– https://univdatos.com/report/multiplex-assay-market/
For a better understanding of the market adoption of multiplex assay, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the multiplex assay industry owing to the presence of various research programs in the region, as well as the expansion of R&D efforts for the creation of new medications and diagnostic and therapeutic approaches. The rise in government financing for the discovery of new biomarkers and the increased frequency of chronic diseases like cancer and stroke are expected to fuel the region’s growth. Furthermore, the rise is probably going to be fueled by the presence of important players in the area.
Some of the major players operating in Luminex Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Becton, Dickinson and Company, Merck KGaA, Seegene Inc., Perkin Elmer Inc., Abcam PLC, Agilent Technologies Inc. among others
Global Multiplex Assay Market Segmentation
Market Insight, by Product
Market Insight, by Type
Market Insight, by Technology
Market Insight, by Application
Market Insight, by End-User
Market Insight, by Region
Top Company Profiles
Get a Callback
By submitting this form, I understand that my data will be processed by Univdatos as indicated above and described in the Privacy Policy. *